Clinical trial
Melphalan in Patients With Neoplastic Meningitis
NCT00002750 · Duke University, Other · Completed
Key facts
| NCT number | NCT00002750 |
|---|---|
| Title | Melphalan in Patients With Neoplastic Meningitis |
| Official title | Phase I of Intrathecal Melphalan in Patients With Recurrent Neoplastic Meningitis |
| Lead sponsor | Duke University, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors, Extragonadal Germ Cell Tumor, Leukemia, Lymphoma, Ovarian Cancer |
| Intervention type | Drug |
| Interventions | melphalan |
| Enrollment | 6 |
| Start date | Dec 1, 1992 |
| Primary completion | May 1, 2001 |
| Completion | May 1, 2001 |
| First posted | May 24, 2004 |
| Last update posted | Feb 20, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: